Similar articles

• Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.

  Gómez AM, Marín Carrillo LF, Muñoz Velandia OM, Rondón Sepúlveda MA, Arévalo Correa CM, Mora Garzón E, Cuervo Diaz MC, Henao Carrillo DC. Gómez AM, et al. Diabetes Technol Ther. 2017 Feb;19(2):109-114. doi: 10.1089/dia.2016.0332. Epub 2016 Dec 21. Diabetes Technol Ther. 2017. PMID: 28001445
• Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.

  Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW. Ly TT, et al. JAMA. 2013 Sep 25;310(12):1240-7. doi: 10.1001/jama.2013.277818. JAMA. 2013. PMID: 24065010 Clinical Trial.
• "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.

  Biester T, Kordonouri O, Holder M, Remus K, Kieninger-Baum D, Wadien T, Danne T. Biester T, et al. Diabetes Technol Ther. 2017 Mar;19(3):173-182. doi: 10.1089/dia.2016.0349. Epub 2017 Jan 18. Diabetes Technol Ther. 2017. PMID: 28099035 Free PMC article.
• Insulin Pumps.

  Pickup JC. Pickup JC. Diabetes Technol Ther. 2017 Feb;19(S1):S19-S26. doi: 10.1089/dia.2017.2503. Diabetes Technol Ther. 2017. PMID: 28192024 Review. No abstract available.
• [Continuous subcutaneous insulin infusion].

  Ito H, Kanatsuka A. Ito H, et al. Nihon Rinsho. 1997 Nov;55 Suppl:267-72. Nihon Rinsho. 1997. PMID: 9434479 Review. Japanese. No abstract available.